Do I Need a Lung Biopsy to Diagnose NSIP Lung Disease?
At a Glance
Many people with nonspecific interstitial pneumonia (NSIP) can receive a working diagnosis without a lung biopsy when their high-resolution CT, medical history, and blood tests are convincing. A biopsy is considered when uncertainty could change treatment and its benefits outweigh the risks.
In this answer
3 sections
A lung biopsy is not always required to diagnose non-specific interstitial pneumonia (NSIP) [1]. (Note: NSIP is a pattern of lung injury and scarring, not an infection, despite the word “pneumonia” in its name.) For many people, a specialized medical team can make a confident working diagnosis using a combination of your clinical history, blood tests to evaluate for autoimmune diseases, and a high-resolution CT (HRCT) scan [2][3]. However, if your imaging is unclear or if your doctors need to rule out other similar lung conditions, a biopsy may be recommended to help guide your treatment plan [4][5].
When Is a Biopsy Necessary?
A multidisciplinary team—a group of pulmonologists, radiologists, and pathologists working together—will carefully review your case before recommending a biopsy [3]. They may suggest holding off on a biopsy if:
- Your HRCT scan shows patterns that are highly suggestive of NSIP, such as ground-glass opacities (hazy areas) and specific patterns of lung scarring [6]. While these findings can overlap with other conditions, an experienced team can integrate them with your clinical picture [7].
- Blood tests, physical examination, and your medical history strongly suggest an underlying connective tissue disease, medication side effect, or environmental exposure that explains your symptoms [2][3].
A biopsy becomes an important option when your diagnosis remains uncertain after this noninvasive evaluation, and when the results would realistically change your medical care [4][5]. For example, a biopsy can help distinguish idiopathic NSIP (where the cause is unknown) from hypersensitivity pneumonitis (an immune reaction to inhaled dusts, molds, or environmental antigens) or idiopathic pulmonary fibrosis (IPF) [4][8]. Knowing the exact pattern of interstitial lung disease may help guide your therapies—such as whether to use immunosuppressants (medicines that calm the immune system) or antifibrotic drugs (medicines that slow lung scarring) [9][5].
Types of Biopsies and Procedures
If your care team determines that a tissue sample is needed, there are several ways to obtain it. The decision depends on your overall health, lung function, and the expertise available at your local medical center.
Bronchoscopy and Washings
During a traditional bronchoscopy, a flexible tube with a camera is passed through your nose or mouth into your airways. Doctors may perform a bronchoalveolar lavage (BAL), which involves washing a small part of the lung with saline and collecting the fluid [10]. BAL is primarily used to evaluate for infections or identify specific immune cells that point to alternative conditions; it does not provide lung tissue architecture [10][11]. Sometimes, doctors will use tiny forceps to grab a piece of lung tissue (transbronchial forceps biopsy). However, these traditional forceps samples are often too small or crushed to reliably distinguish complex patterns like NSIP from other scarring diseases [12][13].
Transbronchial Cryobiopsy
A transbronchial cryobiopsy uses a specialized freezing probe passed through a bronchoscope to instantly freeze and extract a larger piece of lung tissue [14]. It is an alternative tissue-sampling approach that can sometimes help patients avoid surgery, but it requires an experienced ILD center with specialized expertise [15]. The samples are larger and less damaged than traditional forceps biopsies, providing enough tissue to help guide a diagnosis in roughly 75% to 85% of cases in pooled studies [16][14]. However, because the sample is smaller than what is taken in surgery, a higher yield does not guarantee a single definitive cause, and there is still a risk of a nondiagnostic sample that leaves you without clear answers [14].
Surgical Lung Biopsy (VATS)
Video-assisted thoracoscopic surgery (VATS) is a minimally invasive surgical lung biopsy where a surgeon makes small incisions in your chest to remove larger tissue samples [17]. Because surgical biopsies yield the largest and highest-quality tissue samples, they offer the highest confidence for getting a specific tissue pattern diagnosis [14][15]. However, VATS is an operation that typically requires general anesthesia and a hospital stay, carrying more significant recovery time, potential for post-operative pain, and higher overall risks compared to bronchoscopy procedures [15][18].
Understanding the Risks and Recovery
Deciding whether to get a lung biopsy requires a careful conversation about the risks versus the benefits. Local and personal risks can differ substantially from overall statistics, so it is important to ask for your specific center’s complication rates. The risks include:
- Pneumothorax (Collapsed Lung) and Air Leaks: A biopsy can cause air to leak between the lung and the chest wall. In cryobiopsy procedures, pooled study estimates show this happens in about 9.6% of patients [19]. If this occurs, you may need a small tube placed in your chest for a few days to drain the air [19]. Surgical biopsies (VATS) also carry a risk of a prolonged air leak that requires extending your hospital stay [17].
- Bleeding: Bleeding in the airways is a known risk. With cryobiopsy, studies estimate moderate bleeding occurs in around 11.7% of cases, while severe bleeding occurs in about 1.9% [19]. Your team will carefully manage any blood-thinning medications you take prior to the procedure.
- Anesthesia and Oxygenation Issues: Surgical biopsies (VATS) require general anesthesia and mechanical ventilation (a breathing machine) [18]. Cryobiopsy is also commonly performed under general anesthesia or deep sedation with a secured airway to ensure safety and improve sample quality, which carries its own respiratory risks [20][21].
- Acute Exacerbation: Any biopsy procedure on scarred lungs carries a risk of triggering an acute exacerbation—a sudden, severe worsening of your underlying lung disease that can require hospitalization or life support [22]. This complication is uncommon (one study estimated it affects roughly 3.6% of patients undergoing cryobiopsy) but highly dangerous [23][17].
- Respiratory Failure and Death: Both VATS and cryobiopsy carry a rare but severe risk of major respiratory failure, an intensive care unit (ICU) stay, and procedure-related mortality. Studies estimate procedure-attributed mortality at roughly 0.9% for cryobiopsy, and VATS also carries a mortality risk [19][17].
Because of these risks, your care team will carefully evaluate your lung function (like your breathing test scores and oxygen levels) before recommending any procedure. If your lung function is very low or you have severe pulmonary hypertension (high blood pressure in the lung arteries), the risks of a biopsy may outweigh the benefits [24]. After any procedure, you should seek urgent medical help if you experience worsening breathlessness, severe chest pain, significant bleeding, fainting, or fever.
Common questions in this guide
Can doctors diagnose NSIP without taking a lung tissue sample?
Why might a doctor still suggest a biopsy for NSIP?
Which procedures can provide tissue for an NSIP diagnosis?
What complications can happen after a lung biopsy for NSIP?
What should I ask before agreeing to an NSIP lung biopsy?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on Non-specific interstitial pneumonia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What exact HRCT category has the radiologist assigned, and is our working diagnosis confident enough to start treatment without a biopsy?
- 2.If you recommend a biopsy, how will the results specifically change the medications you prescribe for me?
- 3.What alternatives do I have if I choose not to undergo a lung biopsy at this time?
- 4.Do you recommend a cryobiopsy or a surgical biopsy, and what is this center's specific experience with these procedures?
- 5.What are your center's rates of diagnostic success, serious bleeding, prolonged air leak, and severe complications like respiratory failure?
- 6.Will my tissue sample be reviewed by a pathologist specifically trained in interstitial lung diseases?
- 7.What is my personal risk of a sudden exacerbation or needing life support based on my current lung function and oxygen levels?
References
References (24)
- 1
Multidisciplinary approach in the diagnosis of idiopathic nonspecific interstitial pneumonia.
Ovcharenko SI, Son EA, Kapustina VA
Terapevticheskii arkhiv 2019; (91(3)):101-106 doi:10.26442/00403660.2019.03.000077.
PMID: 31094467 - 2
Idiopathic non-specific interstitial pneumonia.
Belloli EA, Beckford R, Hadley R, Flaherty KR
Respirology (Carlton, Vic.) 2016; (21(2)):259-68 doi:10.1111/resp.12674.
PMID: 26564810 - 3
Diagnostic approach of fibrosing interstitial lung diseases of unknown origin.
Cottin V, Valenzuela C
Presse medicale (Paris, France : 1983) 2020; (49(2)):104021 doi:10.1016/j.lpm.2020.104021.
PMID: 32437843 - 4
Transbronchial lung cr onchial lung cryobiopsy for the diagnosis of diffuse obiopsy for the diagnosis of diffuse parenchymal lung disease: Pitfalls and challenges, a single center experience.
Tertemiz KC, Alpaydın AÖ, Güler N, et al.
Turkish journal of medical sciences 2023; (53(1)):100-108 doi:10.55730/1300-0144.5563.
PMID: 36945960 - 5
Clinical Impact of Surgical Lung Biopsy for Interstitial Lung Disease in a Reference Center.
Le Guen P, Iquille J, Debray MP, et al.
The Annals of thoracic surgery 2022; (114(3)):1022-1028 doi:10.1016/j.athoracsur.2021.07.038.
PMID: 34403693 - 6
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia.
Lee J, Kim YH, Kang JY, et al.
Tuberculosis and respiratory diseases 2019; (82(4)):277-284 doi:10.4046/trd.2018.0092.
PMID: 31172700 - 7
Meta-analysis of the radiological and clinical features of Usual Interstitial Pneumonia (UIP) and Nonspecific Interstitial Pneumonia (NSIP).
Ebner L, Christodoulidis S, Stathopoulou T, et al.
PloS one 2020; (15(1)):e0226084 doi:10.1371/journal.pone.0226084.
PMID: 31929532 - 8
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis.
Tomassetti S, Wells AU, Costabel U, et al.
American journal of respiratory and critical care medicine 2016; (193(7)):745-52 doi:10.1164/rccm.201504-0711OC.
PMID: 26562389 - 9
Biopsy in interstitial lung disease: specific diagnosis and the identification of the progressive fibrotic phenotype.
Ravaglia C, Nicholson AG
Current opinion in pulmonary medicine 2021; (27(5)):355-362 doi:10.1097/MCP.0000000000000810.
PMID: 34397611 - 10
Interstitial lung disease: the diagnostic role of bronchoscopy.
Kebbe J, Abdo T
Journal of thoracic disease 2017; (9(Suppl 10)):S996-S1010 doi:10.21037/jtd.2017.06.39.
PMID: 29214060 - 11
Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?
Tomassetti S, Colby TV, Wells AU, et al.
Therapeutic advances in musculoskeletal disease 2021; (13()):1759720X211059605 doi:10.1177/1759720X211059605.
PMID: 34900002 - 12
Transbronchial cryobiopsy in diffuse parenchymal lung diseases.
Poletti V, Ravaglia C, Tomassetti S
Current opinion in pulmonary medicine 2016; (22(3)):289-96 doi:10.1097/MCP.0000000000000272.
PMID: 26989821 - 13
Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease.
Sheth JS, Belperio JA, Fishbein MC, et al.
Chest 2017; (151(2)):389-399 doi:10.1016/j.chest.2016.09.028.
PMID: 27729263 - 14
Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.
Troy LK, Grainge C, Corte TJ, et al.
The Lancet. Respiratory medicine 2020; (8(2)):171-181 doi:10.1016/S2213-2600(19)30342-X.
PMID: 31578168 - 15
Invasive diagnostic techniques in idiopathic interstitial pneumonias.
Poletti V, Ravaglia C, Gurioli C, et al.
Respirology (Carlton, Vic.) 2016; (21(1)):44-50 doi:10.1111/resp.12694.
PMID: 26682637 - 16
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis.
Rodrigues I, Estêvão Gomes R, Coutinho LM, et al.
European respiratory review : an official journal of the European Respiratory Society 2022; (31(166)) doi:10.1183/16000617.0280-2021.
PMID: 36198419 - 17
The role of video-assisted thoracoscopic surgery in the diagnosis of interstitial lung disease.
Sugino K, Otsuka H, Matsumoto Y, et al.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2019; (36(2)):148-156 doi:10.36141/svdld.v36i2.7797.
PMID: 32476948 - 18
Correlation between high-resolution computed tomography appearance and histopathological features in the diagnosis of interstitial lung diseases. A real-life study.
Lyberis P, Verri G, Solidoro P, et al.
Minerva surgery 2024; (79(2)):133-139 doi:10.23736/S2724-5691.23.09948-3.
PMID: 37218142 - 19
Role of Transbronchial Lung Cryobiopsy in the Diagnosis of Interstitial Lung Disease: A Meta-analysis of 68 Studies and 6300 Patients.
Zayed Y, Alzghoul BN, Hyde R, et al.
Journal of bronchology & interventional pulmonology 2023; (30(2)):99-113 doi:10.1097/LBR.0000000000000865.
PMID: 35698283 - 20
A systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease.
Lachowicz JA, Smallwood NE, Prasad JD, et al.
European respiratory review : an official journal of the European Respiratory Society 2024; (33(173)) doi:10.1183/16000617.0035-2024.
PMID: 39142710 - 21
Diagnosis of diffuse parenchymal lung diseases using transbronchial cryobiopsy guided by endobronchial ultrasound compared to clinicoradiological diagnosis.
Li X, Pan J, Ma Y, et al.
Quantitative imaging in medicine and surgery 2022; (12(2)):1139-1148 doi:10.21037/qims-21-255.
PMID: 35111611 - 22
Transbronchial Lung Cryobiopsy in Patients with Interstitial Lung Disease: A Systematic Review.
Kheir F, Uribe Becerra JP, Bissell B, et al.
Annals of the American Thoracic Society 2022; (19(7)):1193-1202 doi:10.1513/AnnalsATS.202102-198OC.
PMID: 35499855 - 23
Acute exacerbation of interstitial lung diseases and mortality post-cryobiopsy: a multicenter cohort study.
Austin A, Jaber J, Fu K, et al.
Journal of thoracic disease 2024; (16(7)):4340-4349 doi:10.21037/jtd-24-270.
PMID: 39144357 - 24
Transbronchial Lung Cryobiopsy in Interstitial Lung Diseases: Best Practice.
Colella S, Haentschel M, Shah P, et al.
Respiration; international review of thoracic diseases 2018; (95(6)):383-391 doi:10.1159/000488910.
PMID: 29894993
This page is for informational purposes only and does not constitute medical advice about NSIP or lung biopsy decisions. Discuss your imaging, lung function, and personal risks with your pulmonologist or interstitial lung disease team.